Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.

AIDS reviews - 1 Jan 2000

Kolber Michael A

Abstract excerpt

Most physicians that treat individuals with HIV-1 disease are able to successfully suppress viral replication with the pharmacologic armamentarium available today. For the majority of patients this results in immune reconstitution and improved quality of life. However, a large fraction of these patients have transient elevations in their viral burden and even persistence of low-level viremia. In fact, many...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Evolution, Molecular

Share to HIV Infections

Share to Mutation

Share to Viral Load

Source

Identifiers

PMID: 17694674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.PMID 17694674Read ↗

Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable?Semantic proximity Read ↗

A virological perspective on resistance in highly treatment-experienced patients.Semantic proximity Read ↗

[Molecular mechanisms for the emergence of drug-resistant HIV-1].Semantic proximity Read ↗

Current Perspectives on HIV-1 Antiretroviral Drug ResistanceSemantic proximity Read ↗

Implications of antiretroviral resistance on viral fitnessSemantic proximity Read ↗

The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject MatterSemantic proximity Read ↗

Effects of drug resistance on viral load in patients failing antiretroviral therapy.Semantic proximity Read ↗

HIV-1 antiretroviral resistance: scientific principles and clinical applications.Semantic proximity Read ↗

Viral resistance: a major challenge in managing HIV disease.Semantic proximity Read ↗

New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?Semantic proximity Read ↗

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.Semantic proximity Read ↗

Mechanism of HIV antiretroviral drugs progress toward drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.